HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure
<p>Abstract</p> <p>In a recent summary of integrase sequences, primary integrase inhibitor mutations were rare. In a review of integrase inhibitor-naïve Australian HIV-1 sequences, primary mutations were not identified, although the accessory mutation G140S was detected. A link wit...
Main Authors: | Wang Bin, Deris Zaquan, Herring Belinda, van Hal Sebastiaan J, Saksena Nitin K, Dwyer Dominic E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-02-01
|
Series: | Retrovirology |
Online Access: | http://www.retrovirology.com/content/6/1/12 |
Similar Items
-
HIV INTEGRASE INHIBITORS: THE BASIS OF EFFECTIVE AND SAFE ANTIRETROVIRAL THERAPY
by: V. I. SHAKHGILDYAN
Published: (2017-05-01) -
Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
by: Hotma Martogi Lorensi Hutapea, et al.
Published: (2018-12-01) -
Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
by: Karolin Meixenberger, et al.
Published: (2017-11-01) -
Genetic diversity and baseline drug resistance of South African HIV-1 Integrase sequences prior to the availability of Integrase strand-transfer inhibitors
by: Brado, Dominik Alexander
Published: (2020) -
Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)